Ms Irene Parcher, LADC in Alna, ME - Counselor

Ms Irene Parcher, LADC is a Counselor - Addiction (substance Use Disorder) based in Alna, Maine. Ms Irene Parcher is licensed to practice in Maine (license number LC6450) and her current practice location is 4 Head Tide Rd, Alna, Maine. She can be reached at her office (for appointments etc.) via phone at (207) 449-8688.

NPI number for Ms Irene Parcher is 1811469067 and her current mailing address is 4 Head Tide Rd, Alna, Maine. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1811469067.

Contact Information

	Ms Irene Parcher, LADC
	4 Head Tide Rd, Alna, ME 04535-3020
	(207) 449-8688
	Not Available

Healthcare Provider's Profile

Full Name	Ms Irene Parcher
Gender	Female
Speciality	Counselor - Addiction (substance Use Disorder)
Location	4 Head Tide Rd, Alna, Maine
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1811469067
Provider Enumeration Date: 12/28/2018
Last Update Date: 12/28/2018

Medical Identifiers

Medical identifiers for Ms Irene Parcher such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1811469067	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YA0400X	Counselor - Addiction (substance Use Disorder)	LC6450 (Maine)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Irene Parcher is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Irene Parcher, LADC 4 Head Tide Rd, Alna, ME 04535-3020 Ph: (207) 449-8688	Ms Irene Parcher, LADC 4 Head Tide Rd, Alna, ME 04535-3020 Ph: (207) 449-8688

News Archive

UCSF awarded grant of $2.7M for collaborative project aimed at reducing premature births

UC San Francisco has been awarded a Bill & Melinda Gates Foundation grant of $2.7 million over three years for a collaborative project aimed at reducing premature births.

Chemed board authorizes additional $100M stock repurchase program

Chemed Corporation announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.

FDA categorizes Nanosphere's RVNATSP assay on Verigene SP System as "Moderate Complexity"

Nanosphere, Inc., a leader in the development and commercialization of advanced molecular diagnostics systems, received notification from the U.S. Food and Drug Administration (FDA) that its respiratory virus panel (RVNATSP) performed on the Verigene SP System has been categorized as "Moderate Complexity" under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

People are more willing to lie to coworkers than to strangers

Though explicit talk of money may be considered gauche, we are frequently confronted with the dreaded query "How much did you pay for that?"

Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C

Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events.

Ms Irene Parcher, LADC - Counselor in Alna, ME